Back to VA VANGUARD CAPITAL MANAGEMENT LLC
NRXP2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in NRX PHARMACEUTICALS INC
Yes. Vanguard Capital Management holds 1,618,159 shares of NRXP (NRX Pharmaceuticals), worth $6.6M, as of its Q2 2026 13F filing. It increased the position by 457,975 shares (+39.5%) from Q1 2026. Vanguard Capital Management has held NRXP in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$6.6M
Current Shares
1.6M
Total Value Change
+$4.1M
Total Shares Change
+457,975
Quarter-by-Quarter History
Other major holders of NRXP: AMERIPRISE FINANCIAL INC, BALYASNY ASSET MANAGEMENT L.P., CITADEL ADVISORS LLC, VANGUARD GROUP INC, COMMONWEALTH EQUITY SERVICES, LLC